Terms: = Prostate cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Clinical Outcome
8 results:
1. Protein kinase D activity is a risk biomarker in prostate cancer that drives cell invasion by a Snail/erk dependent mechanism.
Cilleros-Rodríguez D; Toledo-Lobo MV; Martínez-Martínez D; Baquero P; Angulo JC; Chiloeches A; Iglesias T; Lasa M
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166851. PubMed ID: 37611675
[TBL] [Abstract] [Full Text] [Related]
2. Tumor-secreted Hsp90 subverts polycomb function to drive prostate tumor growth and invasion.
Nolan KD; Franco OE; Hance MW; Hayward SW; Isaacs JS
J Biol Chem; 2015 Mar; 290(13):8271-82. PubMed ID: 25670862
[TBL] [Abstract] [Full Text] [Related]
3. The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer.
Wang T; Liu Z; Guo S; Wu L; Li M; Yang J; Chen R; Xu H; Cai S; Chen H; Li W; Wang L; Hu Z; Zhuang Q; Xu S; Wang L; Liu J; Ye Z; Ji JY; Wang C; Chen K
Oncotarget; 2014 Jun; 5(11):3611-21. PubMed ID: 25003983
[TBL] [Abstract] [Full Text] [Related]
4. TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence.
Zhang Q; Chen L; Helfand BT; Jang TL; Sharma V; Kozlowski J; Kuzel TM; Zhu LJ; Yang XJ; Javonovic B; Guo Y; Lonning S; Harper J; Teicher BA; Brendler C; Yu N; Catalona WJ; Lee C
PLoS One; 2011; 6(9):e25168. PubMed ID: 21980391
[TBL] [Abstract] [Full Text] [Related]
5. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
[TBL] [Abstract] [Full Text] [Related]
6. Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, erk, and PI3K.
Gutiérrez-Cañas I; Juarranz MG; Collado B; Rodríguez-Henche N; Chiloeches A; Prieto JC; Carmena MJ
Prostate; 2005 Apr; 63(1):44-55. PubMed ID: 15468165
[TBL] [Abstract] [Full Text] [Related]
7. Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer.
Kreisberg JI; Malik SN; Prihoda TJ; Bedolla RG; Troyer DA; Kreisberg S; Ghosh PM
Cancer Res; 2004 Aug; 64(15):5232-6. PubMed ID: 15289328
[TBL] [Abstract] [Full Text] [Related]
8. Activation of the erk mitogen-activated protein kinase pathway stimulates neuroendocrine differentiation in LNCaP cells independently of cell cycle withdrawal and STAT3 phosphorylation.
Kim J; Adam RM; Freeman MR
Cancer Res; 2002 Mar; 62(5):1549-54. PubMed ID: 11888934
[TBL] [Abstract] [Full Text] [Related]
